https://www.aqxpharma.com/ 2026-03-11T16:02:07+00:00 https://www.aqxpharma.com/press-and-blog/ 2025-02-07T13:31:41+00:00 https://www.aqxpharma.com/medication/generic-cialis/ 2025-12-23T10:39:25+00:00 https://www.aqxpharma.com/medication/generic-levitra 2023-11-29T12:16:26+00:00 https://www.aqxpharma.com/medication/ivermectin-stromectol-generic 2025-10-09T12:15:42+00:00 https://www.aqxpharma.com/medication/priligy-generic 2024-04-01T09:23:22+00:00 https://www.aqxpharma.com/medication/propecia-generic 2023-08-22T06:06:16+00:00 https://www.aqxpharma.com/medication/caverta 2023-08-22T06:02:28+00:00 https://www.aqxpharma.com/medication/generic-viagra 2025-12-22T12:36:37+00:00 https://www.aqxpharma.com/sitemap 2023-07-31T12:54:00+00:00 https://www.aqxpharma.com/technology/ship1-and-the-pi3k-pathway/ 2023-05-13T14:10:44+00:00 https://www.aqxpharma.com/technology/scientific-meetings-conferences/ 2023-05-13T19:32:50+00:00 https://www.aqxpharma.com/senior-scientist-clinical-research-vancouversan-bruno 2023-05-13T14:06:54+00:00 https://www.aqxpharma.com/senior-manager-information-systems 2023-05-13T14:07:16+00:00 https://www.aqxpharma.com/senior-clinical-scientist 2023-05-13T14:04:05+00:00 https://www.aqxpharma.com/scientist-clinical-research 2023-05-13T14:06:31+00:00 https://www.aqxpharma.com/project-coordinator-medical-affairs 2023-05-13T14:06:35+00:00 https://www.aqxpharma.com/press-releases 2024-12-26T17:21:08+00:00 https://www.aqxpharma.com/node/132 2023-05-13T14:05:39+00:00 https://www.aqxpharma.com/node/127 2023-05-13T14:17:41+00:00 https://www.aqxpharma.com/node/111 2023-05-13T14:17:35+00:00 https://www.aqxpharma.com/node/110 2023-05-13T14:17:30+00:00 https://www.aqxpharma.com/generalist-human-resources 2023-05-13T14:05:18+00:00 https://www.aqxpharma.com/content/working-aquinox 2023-08-09T11:50:03+00:00 https://www.aqxpharma.com/content/vancouver-biotech-company-catching-eye-big-pharma 2023-05-13T19:31:42+00:00 https://www.aqxpharma.com/content/technology 2023-05-13T14:17:17+00:00 https://www.aqxpharma.com/content/ship1-and-pi3k-pathway 2023-05-13T14:22:15+00:00 https://www.aqxpharma.com/content/selected-publications 2023-05-13T19:31:42+00:00 https://www.aqxpharma.com/content/scientific-clinical-meetings-conferences 2023-05-13T19:31:25+00:00 https://www.aqxpharma.com/content/pipeline-product-platform 2023-05-13T14:19:33+00:00 https://www.aqxpharma.com/content/pipeline 2023-08-09T11:48:58+00:00 https://www.aqxpharma.com/content/partners-collaborators 2023-08-09T11:51:59+00:00 https://www.aqxpharma.com/content/media-coverage 2023-05-13T19:31:25+00:00 https://www.aqxpharma.com/content/management 2023-08-09T11:47:30+00:00 https://www.aqxpharma.com/content/investors 2023-08-09T11:53:40+00:00 https://www.aqxpharma.com/content/how-apply 2023-05-13T14:13:48+00:00 https://www.aqxpharma.com/content/history 2023-08-22T08:09:59+00:00 https://www.aqxpharma.com/content/facilities-coordinator 2023-05-13T14:14:57+00:00 https://www.aqxpharma.com/content/discovery-platform 2023-05-13T14:15:32+00:00 https://www.aqxpharma.com/content/director-clinical-operations 2023-05-13T14:15:41+00:00 https://www.aqxpharma.com/content/director-biostatistics-0 2023-05-13T14:15:46+00:00 https://www.aqxpharma.com/content/current-opportunities 2023-08-09T11:50:57+00:00 https://www.aqxpharma.com/content/corporate-profile 2023-08-22T08:11:47+00:00 https://www.aqxpharma.com/content/corporate-presentation 2023-08-09T11:47:56+00:00 https://www.aqxpharma.com/content/chronic-obstructive-pulmonary-disease 2023-05-13T14:21:09+00:00 https://www.aqxpharma.com/content/board-directors 2023-08-09T11:46:56+00:00 https://www.aqxpharma.com/content/bladder-pain-syndrome-interstitial-cystitis 2023-05-13T14:21:16+00:00 https://www.aqxpharma.com/content/big-pharma-venture-firms-pitch-18m-round-phase-2-anti-inflammatory-drug-developer 2023-05-13T14:21:05+00:00 https://www.aqxpharma.com/content/atopic-dermatitis-0 2023-05-13T13:50:18+00:00 https://www.aqxpharma.com/content/associate-director-clinical-operations 2023-05-13T13:52:56+00:00 https://www.aqxpharma.com/content/aqx-1125 2023-05-13T13:55:30+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-prices-initial-public-offering 2023-05-13T19:31:24+00:00 https://www.aqxpharma.com/content/aquinox-cardiome-raising-bcs-profile-among-biotech-investors 2023-05-13T13:53:51+00:00 https://www.aqxpharma.com/content/about-vancouver 2023-12-25T08:18:50+00:00 https://www.aqxpharma.com/content/about-us 2023-05-13T14:03:57+00:00 https://www.aqxpharma.com/contact 2026-01-16T16:09:00+00:00 https://www.aqxpharma.com/aquinox-privacy-policy 2023-05-13T13:53:38+00:00 https://www.aqxpharma.com/bladder-health-month-spotlight-ic 2023-05-13T14:21:00+00:00 https://www.aqxpharma.com/sample-page/ 2023-05-13T01:03:13+00:00 https://www.aqxpharma.com/content/zithromax-dosage-guide/ 2025-02-07T13:31:55+00:00 https://www.aqxpharma.com/content/intermittent-fasting/ 2025-02-04T13:10:03+00:00 https://www.aqxpharma.com/content/busting-pharmacy-myths/ 2025-01-31T15:03:21+00:00 https://www.aqxpharma.com/content/mens-health-in-the-digital-age/ 2025-01-30T14:07:21+00:00 https://www.aqxpharma.com/content/how-cystitis-affects-urinary-health/ 2025-04-18T10:22:05+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-receives-regulatory-clearance-initiate-first-clinical-study-aqx-1125 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-initiates-two-phase-iia-clinical-studies-airway-inflammation 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-commences-phase-ii-clinical-trial-aqx-1125-bladder-pain 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-commences-phase-2-clinical-trial-aqx-1125-chronic-obstructive 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-appoints-csaba-szabo-md-phd-vice-president-research-and-chief 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-announces-first-quarter-2014-financial-results 2023-05-13T19:36:23+00:00 https://www.aqxpharma.com/content/aquinox-pharmaceuticals-announces-closing-initial-public-offering 2023-05-13T19:36:22+00:00